Oziltus (Denosumab-mobz)

•  Oziltus (denosumab-mobz) is a RANK ligand (RANKL) inhibitor indicated for:
  Prevention of skeletal-related events in patients with multiple myeloma and in patients with bone metastases from solid tumors.
• Treatment of adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where surgical resection is likely to result in severe morbidity.
• Treatment of hypercalcemia of malignancy refractory to bisphosphonate therapy

Recommended Dosage:
A healthcare provider should administer Oziltus. It is intended for the subcutaneous route only and should not be administered intravenously, intramuscularly, or intradermally.

• Multiple Myeloma and Bone Metastasis from Solid Tumors: The recommended dose of Oziltus is 120 mg administered as a subcutaneous injection every 4 weeks in the upper arm, upper thigh, or abdomen. Administer calcium and vitamin D as necessary to treat or prevent hypocalcemia.
• Giant Cell Tumor of Bone: The recommended dose of Oziltus is 120 mg administered every 4 weeks with additional 120 mg doses on Days 8 and 15 of the first month of therapy. Administer subcutaneously in the upper arm, upper thigh, or abdomen. Administer calcium and vitamin D as necessary to treat or prevent hypocalcemia.
• Hypercalcemia of Malignancy: The recommended dose of Oziltus is 120 mg administered every 4 weeks with additional 120 mg doses on Days 8 and 15 of the first month of therapy. Administer subcutaneously in the upper arm, upper thigh, or abdomen.

• Monitor calcium levels before starting Oziltus and during treatment, particularly in patients with kidney complications or vitamin D deficiency. Correct low calcium before therapy. Symptoms like tingling, muscle cramps, or confusion should be reported immediately and managed promptly.
• Serious allergic reactions may occur with this treatment. Monitor patients for rash, swelling, difficulty breathing, or serious dizziness. In case of hypersensitivity reactions, stop treatment promptly and provide appropriate medical care to prevent life-threatening complications.
• Osteonecrosis of the jaw may occur, especially in those with dental problems or invasive dental procedures. Maintain good oral hygiene and complete dental check-ups before treatment. Avoid unnecessary dental surgery during therapy and report jaw pain or swelling.
• Unusual thigh or groin pain may indicate atypical femur fractures during long-term treatment. Assess patients with such symptoms promptly. Stop treatment if a fracture is suspected, and provide appropriate orthopedic management to prevent serious complications.
• Oziltus may harm the unborn baby based on its mechanism of action. Do not use during pregnancy. Women of childbearing potential should use effective contraception during treatment and consult their doctor immediately if pregnancy occurs while receiving therapy.
• It is not known if this medicine passes into human breast milk. Because of potential risk to the infant, breastfeeding is not required during treatment and for some time after the last dose. Consult a clinician for guidance before breastfeeding.

What documents are required to import OZILTUS to India?

OZILTUS (denosumab-mobz) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is OZILTUS available in India?

OZILTUS (denosumab-mobz injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Oziltus in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Oziltus price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  Ensuring 100% transparency.

OZILTUS can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, as well as other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of OZILTUS (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please WhatsApp +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for the Oziltus cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source OZILTUS (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Oziltus®?

Denosumab-mobz is the Generic Name for the trade name drug Oziltus®.

What is the Manufacturer’s Name of Oziltus®?

Oziltus® is manufactured by Amneal Pharmaceuticals.

Is Oziltus approved by the FDA?

Yes. Oziltus is approved by the FDA. Date of first approval: December 19, 2025.

What is the dosage and form of Oziltus® supplied?

Oziltus is supplied for injection: 120 mg/1.7 mL (70 mg/mL) solution in a single-dose vial for subcutaneous (SC) use.

What are the most common side effects of Oziltus® injection?

The most commonly reported side effects of Oziltus® in patients with

• Bone Metastasis from Solid Tumors: fatigue/asthenia, hypophosphatemia, and nausea
• Multiple Myeloma: diarrhea, nausea, anemia, back pain, thrombocytopenia, peripheral edema, hypocalcemia, upper respiratory tract infection, rash, and headache.
• Giant Cell Tumor of Bone: arthralgia, headache, nausea, back pain, fatigue, and pain in the extremity.
• Hypercalcemia of Malignancy: nausea, dyspnea, decreased appetite, vomiting, anemia, headache, peripheral edema, constipation, and diarrhea.

How does Oziltus Import in India work?

Oziltus Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Oziltus supplier in India?

Indian Pharma Network is a trusted Oziltus supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Oziltus® injection cost in India?

Oziltus® is not yet approved in India. However, patients in India can legally access it through the provision called the Named Patient Program (NPP). Oziltus prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Oziltus cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Oziltus® injection be available in SAARC countries?

Apart from Gulf countries, Oziltus® injection can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Oziltus® injection in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Oziltus® injection online in India?

Yes, one can buy Oziltus in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Oziltus® injection through legal channels.

Who is an authorized Oziltus importer in India?

Indian Pharma Network acts as an Oziltus importer in India, assisting with Named Patient import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

What are the storage conditions of Oziltus® injection?

Store vials refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze. Protect this therapeutic drug from direct light and heat. Do not vigorously shake Oziltus.